These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35462111)

  • 1. Prognostic impact of micropapillary and solid histological subtype on patients undergoing curative resection for stage I lung adenocarcinoma according to the extent of pulmonary resection and lymph node assessment.
    Jeon YJ; Lee J; Shin S; Cho JH; Choi YS; Kim J; Zo JI; Shim YM; Choi YL; Kim HK
    Lung Cancer; 2022 Jun; 168():21-29. PubMed ID: 35462111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.
    Cox ML; Yang CJ; Speicher PJ; Anderson KL; Fitch ZW; Gu L; Davis RP; Wang X; D'Amico TA; Hartwig MG; Harpole DH; Berry MF
    J Thorac Oncol; 2017 Apr; 12(4):689-696. PubMed ID: 28082103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublobar resection for lung adenocarcinoma meeting node-negative criteria on preoperative imaging.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Ann Thorac Surg; 2014 May; 97(5):1701-7. PubMed ID: 24679941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity-Matched Analysis Comparing Survival After Sublobar Resection and Lobectomy for cT1N0 Lung Adenocarcinoma.
    Chiang XH; Hsu HH; Hsieh MS; Chang CH; Tsai TM; Liao HC; Tsou KC; Lin MW; Chen JS
    Ann Surg Oncol; 2020 Mar; 27(3):703-715. PubMed ID: 31646453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of outcomes following lobectomy, segmentectomy, and wedge resection based on pathological subtyping in patients with pN0 invasive lung adenocarcinoma ≤1 cm.
    Song W; Hou Y; Zhang J; Zhou Q
    Cancer Med; 2022 Dec; 11(24):4784-4795. PubMed ID: 35570370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
    Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
    J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between number of dissected lymph nodes and survival in patients undergoing resection for clinical stage IA pure solid lung adenocarcinoma: a retrospective analysis.
    Rong Y; Liu J; Han N; Shi Z; Jiang T; Zhang N; Xu X; Yin J; Du H
    BMC Pulm Med; 2023 Oct; 23(1):401. PubMed ID: 37865730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association between the presence of solid or micropapillary components and survival outcome in stage ⅠA lung adenocarcinoma cases: a retrospective cohort study].
    Jin KQ; Shen YR; Wu YM; Dai J; Liu XG; Li JQ; Chen LS; Jiang GN
    Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):587-592. PubMed ID: 35658347
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of extensive lymph node dissection in the new grading system for lung adenocarcinoma.
    Liu C; Wang LC; Chang JF; Lin KH; Yeh YC; Hsu PK; Huang CS; Hsieh CC; Hsu HS
    Eur J Surg Oncol; 2024 Oct; 50(10):108540. PubMed ID: 39178686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
    Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
    Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Nodule Density in Women With Sublobar Resection for Stage IA Adenocarcinoma.
    Phillips WW; Gill RR; Mazzola E; Armitage JR; de Forcrand C; Colson YL; Gibney BC
    Ann Thorac Surg; 2021 Oct; 112(4):1067-1075. PubMed ID: 33181131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?
    Ito H; Nakayama H; Murakami S; Yokose T; Katayama K; Miyata Y; Okada M
    Gen Thorac Cardiovasc Surg; 2017 Sep; 65(9):512-518. PubMed ID: 28593420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Extracapsular Lymph Node Involvement and Its Clinicopathological Characteristics in Stage II-IIIA Lung Adenocarcinoma.
    Chen D; Ding Q; Wang W; Wang X; Wu X; Mao Y; Chen C; Chen Y; Zhang Y
    Ann Surg Oncol; 2021 Apr; 28(4):2088-2098. PubMed ID: 33015723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micropapillary and Solid Histologic Patterns in N1 and N2 Lymph Node Metastases Are Independent Factors of Poor Prognosis in Patients With Stages II to III Lung Adenocarcinoma.
    Li Y; Byun AJ; Choe JK; Lu S; Restle D; Eguchi T; Tan KS; Saini J; Huang J; Rocco G; Jones DR; Travis WD; Adusumilli PS
    J Thorac Oncol; 2023 May; 18(5):608-619. PubMed ID: 36681298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential prognostic impact of spread through air spaces in early-stage lung adenocarcinoma after lobectomy according to the pT descriptor.
    Jung W; Chung JH; Yum S; Kim K; Lee CT; Jheon S; Cho S
    J Thorac Cardiovasc Surg; 2022 Jan; 163(1):277-284.e1. PubMed ID: 33158568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with lymph node metastasis upstage after resection for patients with micropapillary lung adenocarcinoma.
    Matsushima K; Sonoda D; Mitsui A; Tamagawa S; Hayashi S; Naito M; Matsui Y; Shiomi K; Satoh Y
    Thorac Cancer; 2022 Jan; 13(1):48-53. PubMed ID: 34866323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validation of prognostic value of pathological staging in pathological stage Ⅰ lung adenocarcinoma].
    Zhang H; Sun FH; Chen ZC; Wang Q
    Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):580-586. PubMed ID: 35658346
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of High-Grade Patterns in Early-Stage Lung Adenocarcinoma: A Multicentric Analysis.
    Bertoglio P; Aprile V; Ventura L; Cattoni M; Nachira D; Lococo F; Perez MR; Guerrera F; Minervini F; Querzoli G; Bocchialini G; Bacchin D; Franzi F; Rindi G; Bellafiore S; Femia F; Bogina GS; Solli P; Kestenholz P; Ruffini E; Paci M; Margaritora S; Imperatori AS; Lucchi M; Gnetti L; Terzi AC
    Lung; 2022 Oct; 200(5):649-660. PubMed ID: 35988096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Spread Through Air Spaces Is a Predictor of Occult Lymph Node Metastasis in Clinical Stage IA Lung Adenocarcinoma.
    Vaghjiani RG; Takahashi Y; Eguchi T; Lu S; Kameda K; Tano Z; Dozier J; Tan KS; Jones DR; Travis WD; Adusumilli PS
    J Thorac Oncol; 2020 May; 15(5):792-802. PubMed ID: 32007599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of prognostic impact of lymphovascular invasion in stage IA non-small cell lung cancer after lobectomy versus sublobar resection: A propensity score-matched analysis.
    Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Lung Cancer; 2020 Aug; 146():105-111. PubMed ID: 32526600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.